Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

Otros/as autores/as

Institut Català de la Salut

[Vinci L, Noellke P, Lebrecht D] Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [Flotho C] Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. German Cancer Consortium (DKTK), Heidelberg and Freiburg, Freiburg, Germany. [Masetti R] Pediatric Oncology and Hematology, IRCCS Azienda OspedalieroUniversitaria di Bologna, Bologna, Italy. [de Haas V] Princess Maxima Center, Diagnostic Laboratory/DCOG Laboratory, Utrecht, The Netherlands. [Diaz de Heredia C] Unitat de Trasplantament de Progenitors Hematopoètics, Servei d'Hematologia i Oncologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2023-06-23T11:12:42Z

2023-06-23T11:12:42Z

2023-05



Resumen

Myeloproliferative disease; Paediatrics


Enfermedad mieloproliferativa; Pediatría


Malaltia mieloproliferativa; Pediatria


Open Access funding enabled and organized by Projekt DEAL.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Springer Nature

Documentos relacionados

Bone Marrow Transplantation;58

https://doi.org/10.1038/s41409-023-01942-4

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)